Abstract
Biopure’s hemoglobin-based oxygen carrier, HBOC-201 (Hemopure®), enhances oxygen transport by promoting both the convective and diffusive components of transport in the microcirculation. Convective transport is modified by HBOC-201 in three ways; (i) volume expansion promotes organ and tissue perfusion, (ii) the low viscosity of HBOC-201 improves flow to tissues, and (iii) oxygen delivery by HBOC Hb in the plasma is relatively insensitive to mechanisms regulating RBC distribution in the microcirculation. Diffusive oxygen transport is increased by the higher P50 compared with native RBC Hb which increases the off-loading of oxygen to tissues. Oxygen transport is also increased by reducing the diffusional barrier to oxygen transport associated with the plasma, in which oxygen is sparingly soluble. Biopure’s HBOC solutions have been shown in vitro and in vivo to take up and off-load oxygen more efficiently than RBC Hb, and when added to blood can increase the efficiency of RBC oxygen transport.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- Hb:
-
hemoglobin
- HBOC:
-
hemoglobin-based oxygen carrier
- HBOC-201:
-
Hemopure®
- HBOC-301:
-
Oxyglobin®
- pO2 :
-
partial pressure of oxygen
References
Hudetz AG, Wood JD, Biswal BB, Krolo I, Kampine, JP. Effect of hemodilution on RBC velocity, supply rate, and hematocrit in the cerebral capillary network. J. Appl Physiol 1999; 87(2):505–509.
Hellums, JD The resistance to oxygen transport in the capillaries relative to that in the surrounding tissue,. Microvas Res 1977;13: 131–136.
Page, TC, McKay, CB, Light, WR, Hellums, JD. Experimental simulation of oxygen transport in microvessels. In RM Winslow, KD Vandegriff, and M Intaglietta, editors. Blood Substitutes: New Challenges. Boston: Birkhauser, 1996, 132–145.
Page, TC, Light, WR, McKay, CB, and Hellums, JD. Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance. Microvas Res 1998; 55:54–64.
Page, TC, Light, WR, and Hellums, JD. Prediction of microcirulatory oxygen transport by erythrocytes/hemoglobin solution mixtures. Microvas Res 1998; 56:113–126.
Page TC, Light, WR, and Hellums, JD. Oxygen transport in 10 µm artificial capillaries In Oxygen Transport to Tissue XXI. New York: Kluwer Academic/Plenum Publishers, 1999, 715–722.
Horn, E-P, Standl, T, Wilhelm, S, Jacobs, EE, Freitag, U, Freitag, M. Bovine hemoglobin increases skeletal muscle oxygenation during 95% artificial arterial stenosis. Surgery 1997; 121:411–418.
Standl, T, Horn, P, Wilhelm, S, Greim, C, Freitag, M, Freitag, U. Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs. Can. J. Anesth. 1996; 43: 714–723.
Cole, P.A., Caswell, JE, Jones, SP, Lefer, DJ. A novel blood substitute protects against myocardial reperfusion injury. ISOTT, 1999;Abstr 53.
Hayward, R, Lefer, AM. Administration of polymerized bovine hemoglobin improves survival in a rat model of traumatic shock. Methods Find Exp Clin Pharmacol 1999; 21(6):427–433.
Teicher, BA, Schwartz, GN, Sotomayor, EA, et al. Oxygenation of tumors by a hemoglobin solution. J Cancer Res Clin Oncol 1993; 120:85–90.
Teicher, BA, Holden, SA, Menon, K, Hopkins, RE, Gawryl, MS. Effect of hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents. Cancer Chemother Pharmacol 1993; 33:57–62.
Teicher, BA Dupus, NP, Emi, Y, et al. Increased efficacy of chemo-and radio-therapy by a hemoglobin solution in the 9L gliosarcoma. in vivo 1995; 9: 11–18.
Al-Halla Q, Al-Halla HA, River, JN, Zamora, M, Oikawa, H, Karczmar, GS. Correlation of magnetic resonance and oxygen microelectode measurements of carbogen-induced changes in tumor oxygenation. Int. J. Rad Oncol Biol Phys 1998; 41(1):l51–159.
Hughes, G.S, Antal, EJ, Locker, PK, Francom, SF, Adams, WJ, Jacobs, EE.Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Med. 1996; 24:756764.
Hughes, GS, Yancey, E.P, Albrecht, R, Locker, PK, Francom, SF, Orringer, EP, Antal, EJ, Jacobs, EE. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans. Clin Pharmacol Ther 1995; 58434–443.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pearce, L.B., Gawryl, M.S. (2003). The Pharmacology of Tissue Oxygenation by Biopure’s Hemoglobin-Based Oxygen Carrier, Hemopure® (HBOC-201). In: Dunn, J.F., Swartz, H.M. (eds) Oxygen Transport to Tissue XXIV. Advances in Experimental Medicine and Biology, vol 530. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0075-9_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0075-9_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4912-9
Online ISBN: 978-1-4615-0075-9
eBook Packages: Springer Book Archive